Get the Stockscreener App
608.89
3.76%
22.06
After Hours:
608.89
Medpace Holdings Inc stock is traded at $608.89, with a volume of 203.95K.
It is up +3.76% in the last 24 hours and up +11.09% over the past month.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
See More
Previous Close:
$586.83
Open:
$587.45
24h Volume:
203.95K
Relative Volume:
0.74
Market Cap:
$17.15B
Revenue:
$2.23B
Net Income/Loss:
$418.30M
P/E Ratio:
45.28
EPS:
13.4469
Net Cash Flow:
$579.82M
1W Performance:
+7.04%
1M Performance:
+11.09%
6M Performance:
+89.39%
1Y Performance:
+78.00%
1-Day Range:
$586.25
$611.70
1-Week Range:
$551.00
$611.70
52-Week Range:
$250.05
$626.25
Medpace Holdings Inc Stock (MEDP) Company Profile
Name
Medpace Holdings Inc
Sector
Industry
Phone
(513) 579-9911
Address
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MEDP
Medpace Holdings Inc
|
608.89 | 16.53B | 2.23B | 418.30M | 579.82M | 13.45 |
|
TMO
Thermo Fisher Scientific Inc
|
620.72 | 229.63B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
236.59 | 166.25B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
706.83 | 54.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.60 | 40.52B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
240.53 | 39.95B | 15.90B | 1.28B | 2.21B | 7.2842 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-02-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-03-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jul-29-25 | Downgrade | UBS | Neutral → Sell |
| Jul-23-25 | Downgrade | TD Cowen | Hold → Sell |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Apr-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Mar-24-25 | Initiated | Leerink Partners | Market Perform |
| Oct-23-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-27-24 | Downgrade | UBS | Buy → Neutral |
| Sep-25-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-01-24 | Initiated | Truist | Hold |
| May-29-24 | Initiated | TD Cowen | Buy |
| May-28-24 | Initiated | Mizuho | Buy |
| Apr-23-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-24 | Initiated | Deutsche Bank | Hold |
| Feb-15-24 | Upgrade | UBS | Neutral → Buy |
| Oct-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-08-23 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-27-22 | Upgrade | UBS | Sell → Neutral |
| Sep-07-22 | Initiated | UBS | Sell |
| May-24-22 | Initiated | Guggenheim | Neutral |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Oct-02-20 | Upgrade | Truist | Hold → Buy |
| Jun-08-20 | Upgrade | Robert W. Baird | Underperform → Neutral |
| May-13-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-30-20 | Upgrade | SunTrust | Sell → Hold |
| Apr-20-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Mar-17-20 | Downgrade | SunTrust | Hold → Sell |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Oct-31-18 | Upgrade | SunTrust | Hold → Buy |
| Sep-17-18 | Initiated | SunTrust | Hold |
| Jul-31-18 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-01-17 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-29-17 | Initiated | Raymond James | Mkt Perform |
| Jul-10-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Medpace Holdings Inc Stock (MEDP) Latest News
Medpace Holdings, Inc. to report fourth quarter and fiscal year 2025 financial results on February 9, 2026 - marketscreener.com
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026 - Investing News Network
Medpace Holdings: Quiet Climb Or Topping Out? What The Numbers Really Say About MEDP - AD HOC NEWS
Medpace Holdings: Can This Quiet Compounder Keep Beating Wall Street’s Playbook? - AD HOC NEWS
What analysts say about Rising Dragon Acquisition Corp stockResistance Zone Identification & High Return Stock Ideas - earlytimes.in
Why Medpace (MEDP) Dipped More Than Broader Market Today - Yahoo Finance
Medpace Holdings, Inc. $MEDP Shares Bought by Abacus FCF Advisors LLC - MarketBeat
Will Medpace Holdings Inc. stock reach Wall Street targetsPrice-to-Book Ratio Updates & Small Investment Growth Plans - bollywoodhelpline.com
Osaic Holdings Inc. Raises Stake in Medpace Holdings, Inc. $MEDP - MarketBeat
Medpace Holdings, Inc. $MEDP Holdings Lifted by Annex Advisory Services LLC - MarketBeat
Medpace Holdings, Inc. $MEDP Shares Sold by PineStone Asset Management Inc. - MarketBeat
Cwm LLC Has $14.65 Million Holdings in Medpace Holdings, Inc. $MEDP - MarketBeat
Medpace Holdings, Inc. (NASDAQ:MEDP) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Rice Hall James & Associates LLC Decreases Stock Holdings in Medpace Holdings, Inc. $MEDP - MarketBeat
Pacer Advisors Inc. Buys 68,384 Shares of Medpace Holdings, Inc. $MEDP - MarketBeat
Medpace and Edgewise Therapeutics Advance Becker Muscular Dystrophy Study - MSN
Medpace Holdings, Inc. $MEDP Shares Sold by Swedbank AB - MarketBeat
Medpace (MEDP): Has the Recent Pullback Opened a Valuation Opportunity for Long‑Term Investors? - Yahoo Finance
Medpace Holdings, Inc. $MEDP Stock Holdings Lessened by Voya Investment Management LLC - MarketBeat
Assessing Medpace Holdings After a 70% Rally and Recent Pullback in 2025 - Yahoo Finance
A Look At The Intrinsic Value Of Medpace Holdings, Inc. (NASDAQ:MEDP) - 富途牛牛
Medpace Holdings, Inc. $MEDP Shares Acquired by Brighton Jones LLC - MarketBeat
Riverbridge Partners LLC Has $187.71 Million Stock Holdings in Medpace Holdings, Inc. $MEDP - MarketBeat
Congress Asset Management Co. Buys 7,190 Shares of Medpace Holdings, Inc. $MEDP - MarketBeat
Medpace price target raised to $525 from $485 at Barclays - MSN
Buyback Watch: Will Medpace Holdings Inc. stock continue dividend increasesJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - moha.gov.vn
Is Medpace Holdings Inc. stock a top momentum playMarket Risk Summary & Fast Entry and Exit Trade Plans - Улправда
Surprises Report: Is Resources Connection Inc stock affected by interest rate hikesMarket Sentiment Review & Risk Managed Trade Strategies - moha.gov.vn
What downside risks could hit Medpace Holdings Inc. (01P) stockDollar Strength & Low Drawdown Investment Ideas - Улправда
Will Medpace Holdings Inc. stock rally after Fed decisionsJuly 2025 Analyst Calls & Free Real-Time Market Sentiment Alerts - Улправда
Wall Street Zen Downgrades Medpace (NASDAQ:MEDP) to Hold - MarketBeat
Medpace (MEDP) Outperforms Broader Market: What You Need to Know - sharewise.com
Can Medpace Holdings Inc. stock resist market sell offsJuly 2025 Opening Moves & Daily Volume Surge Trade Alerts - Bölüm Sonu Canavarı
Why analysts upgrade Medpace Holdings Inc. stockJuly 2025 Setups & Community Verified Trade Signals - DonanımHaber
Is Medpace Holdings Inc. stock trading at a premium valuationJuly 2025 Volume & Weekly High Momentum Picks - DonanımHaber
Will Medpace Holdings Inc. stock continue dividend increasesWeekly Profit Analysis & Accurate Buy Signal Notifications - DonanımHaber
Is Medpace Holdings Inc. stock undervalued vs historical averagesMarket Activity Recap & Fast Gain Stock Tips - Улправда
Can Medpace Holdings Inc. (01P) stock sustain breakout momentumGlobal Markets & Trade Opportunity Analysis - Улправда
Medpace Holdings Inc Stock Warning Signs - GuruFocus
Energy Moves: Why Medpace Holdings Inc. stock remains undervaluedJuly 2025 Price Swings & Safe Swing Trade Setups - Улправда
Is Medpace Holdings Inc. stock cheap at current valuationWeekly Stock Analysis & Daily Profit Focused Stock Screening - Улправда
Medpace Holdings, Inc. $MEDP Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Texas Permanent School Fund Corp Buys 2,313 Shares of Medpace Holdings, Inc. $MEDP - MarketBeat
Barclays Maintains Medpace Holdings (MEDP) Underweight Recommendation - Nasdaq
Advisory Services Network LLC Sells 2,312 Shares of Medpace Holdings, Inc. $MEDP - MarketBeat
Medpace Holdings (MEDP) Surged Following the Strong Results - Insider Monkey
Medpace Holdings, Inc. $MEDP Shares Sold by Ranger Investment Management L.P. - MarketBeat
How Medpace’s Q3 2025 Surge and Buybacks Strategy Could Impact Medpace Holdings (MEDP) Investors - Yahoo Finance
Medpace Holdings, Inc. $MEDP is Bares Capital Management Inc.'s 8th Largest Position - MarketBeat
Globeflex Capital L P Increases Stock Holdings in Medpace Holdings, Inc. $MEDP - MarketBeat
Medpace Holdings Inc Stock (MEDP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Medpace Holdings Inc Stock (MEDP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Troendle August J. | CEO |
Dec 03 '25 |
Sale |
590.69 |
668 |
394,581 |
646,184 |
| BURWIG SUSAN E | Exec. VP, Operations |
Dec 02 '25 |
Option Exercise |
107.93 |
10,000 |
1,079,300 |
37,500 |
| Troendle August J. | CEO |
Dec 01 '25 |
Sale |
593.25 |
23,178 |
13,750,348 |
652,550 |
| Troendle August J. | CEO |
Dec 02 '25 |
Sale |
590.47 |
5,698 |
3,364,498 |
646,852 |
| Troendle August J. | CEO |
Nov 26 '25 |
Sale |
606.88 |
41,331 |
25,082,957 |
690,879 |
| Troendle August J. | CEO |
Nov 28 '25 |
Sale |
593.46 |
15,151 |
8,991,512 |
675,728 |
| Troendle August J. | CEO |
Nov 24 '25 |
Sale |
607.78 |
59,025 |
35,874,214 |
774,602 |
| Troendle August J. | CEO |
Nov 25 '25 |
Sale |
615.52 |
42,392 |
26,093,124 |
732,210 |
| BURWIG SUSAN E | Exec. VP, Operations |
Nov 24 '25 |
Sale |
609.15 |
20,000 |
12,183,000 |
27,500 |
2.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):